INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
Search

All disclosures

Every ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.

Results

Data sources
SEC Form 43h ago
House PTR3h ago
SEC 13F3h ago
Robinhood Chain3h ago

Results

26,449 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
38
HL
Hoff LarryDirector
RVSBRIVERVIEW BANCORP INC
Open-market purchase
BUY$10K
1,920 sh
May 5, 2026May 7, 2026
Page 386 of 662
← PrevNext →
traded May 5, 2026
+2d
SEC Form 4

Evidence

36
WL
Walsh Elizabeth L.Director
CARECarter Bankshares, Inc.
Open-market purchase
BUY$120K
4,575 sh
May 6, 2026May 7, 2026
traded May 6, 2026
+1dSEC Form 4

Evidence

36
DJ
Deegan Brian JohnGroup Chief Accounting Officer
HGHamilton Insurance Group, Ltd.
Open-market sale
SELL$338K
11.0K sh
May 5, 2026May 7, 2026
traded May 5, 2026
+2dSEC Form 4

Evidence

36
NM
Norsa MicheleDirector
ZGNErmenegildo Zegna N.V.
Open-market sale
SELL$47K
4,000 sh
May 5, 2026May 7, 2026
traded May 5, 2026
+2dSEC Form 4

Evidence

36
CL
Campbell Renee LSVP, Capital Markets & Risk
VMIVALMONT INDUSTRIES INC
Open-market sale
SELL$215K
412 sh
May 6, 2026May 7, 2026
traded May 6, 2026
+1dSEC Form 4

Evidence

36
HJ
Holt Adrian JamesSVP, Chf HR Ofcr
EMNEASTMAN CHEMICAL CO
Open-market sale
SELL$132K
1,709 sh
May 5, 2026May 7, 2026
traded May 5, 2026
+2dSEC Form 4

Evidence

36
GQ
Guo Jack Q.EVP & CFO
CSTMCONSTELLIUM SE
Open-market sale
SELL$822K
25.2K sh
May 5, 2026May 7, 2026
traded May 5, 2026
+2dSEC Form 4

Evidence

32
David J. TaylorRSelf
AVGOBroadcom Inc.
Sale
SELL$1,001 – $15KApr 27, 2026May 7, 2026
traded Apr 27, 2026
+10dHouse PTR

Evidence

32
David J. TaylorRSelf
AVGOBroadcom Inc.
Sale
SELL$1,001 – $15KApr 27, 2026May 7, 2026
traded Apr 27, 2026
+10dHouse PTR

Evidence

30
David J. TaylorRSelf
VVISA INC.
Purchase
BUY$1,001 – $15KApr 27, 2026May 7, 2026
traded Apr 27, 2026
+10dHouse PTR

Evidence

30
BL
Brown Claude LeonardChief Business Officer
PINSPINTEREST, INC.
Open-market sale
SELL$1.27M
61.0K sh
May 6, 2026May 7, 2026
traded May 6, 2026
+1dSEC Form 4

Evidence

30
CM
Chan MitchellDirector
AVTXAvalo Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$72K
3,167 sh
May 6, 2026May 7, 2026
traded May 6, 2026
+1dSEC Form 4

Evidence

29
DM
Doyle MittieChief Medical Officer
AVTXAvalo Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$426K
19.0K sh
May 6, 2026May 7, 2026
traded May 6, 2026
+1dSEC Form 4

Evidence

29
DM
Doyle MittieChief Medical Officer
AVTXAvalo Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$953K
44.9K sh
May 6, 2026May 7, 2026
traded May 6, 2026
+1dSEC Form 4

Evidence

28
JC
Jaime CesarDirector
PTENPATTERSON UTI ENERGY INC
Open-market sale
SELL$123K
10.0K sh
May 5, 2026May 7, 2026
traded May 5, 2026
+2dSEC Form 4

Evidence

28
RF
Robin Jodi F.General Counsel and Secretary
TRSTRIMAS CORP
Open-market sale
SELL$123K
3,000 sh
May 5, 2026May 7, 2026
traded May 5, 2026
+2dSEC Form 4

Evidence

27
David J. TaylorRSelf
HDHOME DEPOT, INC.
Sale
SELL$1,001 – $15KApr 27, 2026May 7, 2026
traded Apr 27, 2026
+10dHouse PTR

Evidence

26
SR
Sullivan Christopher RyanChief Financial Officer
AVTXAvalo Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$201K
8,900 sh
May 6, 2026May 7, 2026
traded May 6, 2026
+1dSEC Form 4

Evidence

26
GP
Gallagher Thomas P.Director, Chairman & CEO
MIAXMIAMI INTERNATIONAL HOLDINGS, INC.
Open-market sale · 10b5-1 plan
SELL$756K
15.8K sh
May 5, 2026May 7, 2026
traded May 5, 2026
+2dSEC Form 4

Evidence

26
DM
Doyle MittieChief Medical Officer
AVTXAvalo Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$230K
10.1K sh
May 6, 2026May 7, 2026
traded May 6, 2026
+1dSEC Form 4

Evidence

25
DM
Doyle MittieChief Medical Officer
AVTXAvalo Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$496K
27.5K sh
May 6, 2026May 7, 2026
traded May 6, 2026
+1dSEC Form 4

Evidence

25
SR
Sullivan Christopher RyanChief Financial Officer
AVTXAvalo Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$257K
13.8K sh
May 6, 2026May 7, 2026
traded May 6, 2026
+1dSEC Form 4

Evidence

25
NM
Neagle MatthewChief Operating Officer
PRCHPorch Group, Inc.
Open-market sale
SELL$634K
60.8K sh
May 5, 2026May 7, 2026
traded May 5, 2026
+2dSEC Form 4

Evidence

24
RF
Robin Jodi F.General Counsel and Secretary
TRSTRIMAS CORP
Open-market sale
SELL$83K
2,000 sh
May 7, 2026May 7, 2026
traded May 7, 2026
+0dSEC Form 4

Evidence

24
Greg StantonDSpouse
TCNNFTRULIEVE CANNABIS CORP
Partial sale
SELL$15K – $50KMay 6, 2026May 7, 2026
traded May 6, 2026
+1dHouse PTR

Evidence

23
EP
Enguent Jean-PierreVice President, R&DSS
LAESSEALSQ Corp
Open-market sale · 10b5-1 plan
SELL$47K
15.0K sh
May 6, 2026May 7, 2026
traded May 6, 2026
+1dSEC Form 4

Evidence

22
TS
Tabak ShawnCHIEF FINANCIAL OFFICER
PRCHPorch Group, Inc.
Open-market sale
SELL$111K
10.6K sh
May 5, 2026May 7, 2026
traded May 5, 2026
+2dSEC Form 4

Evidence

22
SR
Sullivan Christopher RyanChief Financial Officer
AVTXAvalo Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$238K
12.3K sh
May 6, 2026May 7, 2026
traded May 6, 2026
+1dSEC Form 4

Evidence

22
SR
Sullivan Christopher RyanChief Financial Officer
AVTXAvalo Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$197K
9,219 sh
May 6, 2026May 7, 2026
traded May 6, 2026
+1dSEC Form 4

Evidence

22
CG
Canup Edward GCHIEF BANKING OFFICER
CBANCOLONY BANKCORP INC
Open-market purchase
BUY$20K
1,000 sh
May 5, 2026May 7, 2026
traded May 5, 2026
+2dSEC Form 4

Evidence

21
VJ
Viana Antonio JDirector
AIPArteris, Inc.
Open-market sale · 10b5-1 plan
SELL$601K
20.0K sh
May 5, 2026May 7, 2026
traded May 5, 2026
+2dSEC Form 4

Evidence

20
David J. TaylorRSelf
PGPROCTER & GAMBLE Co
Purchase
BUY$1,001 – $15KApr 27, 2026May 7, 2026
traded Apr 27, 2026
+10dHouse PTR

Evidence

20
David J. TaylorRSelf
HDHOME DEPOT, INC.
Purchase
BUY$1,001 – $15KApr 27, 2026May 7, 2026
traded Apr 27, 2026
+10dHouse PTR

Evidence

20
David J. TaylorRSelf
PGRPROGRESSIVE CORP/OH/
Purchase
BUY$1,001 – $15KApr 27, 2026May 7, 2026
traded Apr 27, 2026
+10dHouse PTR

Evidence

20
David J. TaylorRSelf
PGPROCTER & GAMBLE Co
Purchase
BUY$1,001 – $15KApr 27, 2026May 7, 2026
traded Apr 27, 2026
+10dHouse PTR

Evidence

19
DM
Doyle MittieChief Medical Officer
AVTXAvalo Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$27K
1,679 sh
May 5, 2026May 7, 2026
traded May 5, 2026
+2dSEC Form 4

Evidence

18
SR
Sullivan Christopher RyanChief Financial Officer
AVTXAvalo Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$56K
2,700 sh
May 6, 2026May 7, 2026
traded May 6, 2026
+1dSEC Form 4

Evidence

18
DM
Doyle MittieChief Medical Officer
AVTXAvalo Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$98K
5,000 sh
May 6, 2026May 7, 2026
traded May 6, 2026
+1dSEC Form 4

Evidence

16
David J. TaylorRSelf
LRCXLAM RESEARCH CORP
Sale
SELL$1,001 – $15KApr 27, 2026May 7, 2026
traded Apr 27, 2026
+10dHouse PTR

Evidence

16
David J. TaylorRSelf
LRCXLAM RESEARCH CORP
Sale
SELL$1,001 – $15KApr 27, 2026May 7, 2026
traded Apr 27, 2026
+10dHouse PTR

Evidence